StockData

Niki BioSolutions, Inc. (NIKI) stock

NIKINasdaqMeasuring & Controlling Devices, NECFiscal year ends December 31
Financials through Q4 FY2025, quarter ended Dec 31, 2025Last filing: 20-F on Mar 27, 2026Score 4/30
$1.60+0.10 (+6.67%)

Close on Nov 18, 2026Market cap $13.03MP/E –Yield –

Earnings

Niki BioSolutions's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
–
Not yet scheduled
Revenue, Q2 FY2022
$527.46K
EPS, Q2 FY2022
-$0.05
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Niki BioSolutions's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q3 FY2024ended Sep 30, 2024Dec 20, 2024after the close–––Release
Q2 FY2022ended Jun 30, 2022Sep 30, 2022after the close$527.46K–-$0.05Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Niki BioSolutions has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Niki BioSolutions puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases Niki BioSolutions filed with the SEC as exhibits to Form 8-K or 6-K

  1. News
  2. News
  3. News
  4. 6-K
  5. 6-K
  6. 6-K
  7. 6-K
  8. 6-K
  9. 6-K
  10. 6-K
  11. 6-K
  12. 6-K
  13. 6-K
  14. 6-K
  15. 6-K

See a number that looks wrong?